University of Munich, Dept. of Neurology, Friedrich-Baur-Institut
Welcome,         Profile    Billing    Logout  
 12 Trials 
27 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Delatycki, Martin
NCT03933163: Micronised Resveratrol as a Treatment for Friedreich Ataxia

Completed
2
25
RoW
Resveratrol
Murdoch Childrens Research Institute
Friedreich Ataxia
03/24
03/24
NCT04157595: Mackenzie's Mission: The Australian Reproductive Carrier Screening Project

Active, not recruiting
N/A
18302
RoW
Reproductive Genetic Carrier Screening
Murdoch Childrens Research Institute, Australian Government Department of Health and Ageing, The University of New South Wales, The University of Western Australia, Harry Perkins Institute of Medical Research, University of Sydney, Macquarie University, Australia, Griffith University, Victorian Clinical Genetics Services, NSW Health Pathology, PathWest Laboratory Medicine WA, King Edward Memorial Hospital, Royal Brisbane and Women's Hospital, Women's and Children's Hospital, Australia, Sydney Children's Hospitals Network, Royal Hobart Hospital
X-Linked Genetic Diseases, Autosomal Recessive Disorder
03/22
12/24
TRACK-FA, NCT04349514: A Natural History Study to TRACK Brain and Spinal Cord Changes in Individuals with Friedreich Ataxia

Active, not recruiting
N/A
300
Europe, Canada, US, RoW
Natural history
Monash University, University of Minnesota, RWTH Aachen University, University of Campinas, Brazil, Children's Hospital of Philadelphia, University of Florida, Friedreich's Ataxia Research Alliance, McGill University
Friedreich Ataxia
10/25
10/25
FA-COMS, NCT03090789: FA Clinical Outcome Measures

Active, not recruiting
N/A
2000
Canada, US, RoW
Friedreich's Ataxia Research Alliance, University of Rochester, Children's Hospital of Philadelphia
Friedreich Ataxia, Neuro-Degenerative Disease
01/30
01/30
UNIFAI, NCT06016946: Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Recruiting
N/A
3000
Europe, Canada, US, RoW
Friedreich's Ataxia Research Alliance
Friedreich Ataxia
01/48
01/48
Klopstock, Thomas
NCT04604548: The KHENEREXT Study

Completed
2
11
Europe
Oral administration of 100 mg KH176 twice daily
Khondrion BV, Julius Clinical, ProPharma Group, Certara
Mitochondrial Diseases, Mitochondrial DNA tRNALeu(UUR) m.3243A
06/23
06/23
STRIDE, NCT04535609 / 2020-002855-40: An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients

Completed
2
213
Europe, Canada, US, RoW
Mavodelpar, REN001, Placebo
Reneo Pharma Ltd
Primary Mitochondrial Myopathy
09/23
10/23
PMD-OPTION, NCT05972954 / 2022-003307-16: OMT-28 in Patients With Primary Mitochondrial Disease (PMD)

Active, not recruiting
2
32
Europe
OMT-28
Omeicos Therapeutics GmbH, OMEICOS Therapeutics GmbH
Primary Mitochondrial Disease
03/25
06/25
PROFA, NCT05943002: Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia

Recruiting
N/A
200
Europe
German Center for Neurodegenerative Diseases (DZNE), McMaster University, Sorbonne University
Friedreich Ataxia
08/24
10/24
EFACTS, NCT02069509: Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies

Recruiting
N/A
1200
Europe, RoW
European Friedreich's Ataxia Consortium for Translational Studies
Friedreich's Ataxia
12/24
12/24
NCT06623890: A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it for the First Time

Recruiting
N/A
300
Europe, US, RoW
Omaveloxolone, SKYCLARYS, BIIB141
Reata, a wholly owned subsidiary of Biogen
Friedreich Ataxia
10/29
10/29
SPORTAX-NHS, NCT02701036: Sporadic Degenerative Ataxia With Adult Onset: Natural History Study

Recruiting
N/A
300
Europe
Ataxia Study Group, German Center for Neurodegenerative Diseases (DZNE)
Late Onset Sporadic Cerebellar Ataxia
12/30
12/30
HSP-PBP, NCT03981276: Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders

Recruiting
N/A
2000
Europe
Clinical rating scale to measure disease severity and progression, Spastic Paraplegia Rating Scale (SPRS), Next-Gen Sequencing (NGS)
Dr. Rebecca Schule, German Federal Ministry of Education and Research, German Center for Neurodegenerative Diseases (DZNE)
Hereditary Spastic Paraplegia
08/39
08/41
UNIFAI, NCT06016946: Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Recruiting
N/A
3000
Europe, Canada, US, RoW
Friedreich's Ataxia Research Alliance
Friedreich Ataxia
01/48
01/48
NCT05554835: Global Registry and Natural History Study for Mitochondrial Disorders

Recruiting
N/A
6000
Europe
LMU Klinikum, European Commission, German Federal Ministry of Education and Research, University of Pisa
Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO, SCAE, NARP Syndrome, MELAS Syndrome, MERRF Syndrome, Coenzyme Q10 Deficiency, LHON, MNGIE, MIRAS, Barth Syndrome, MDS, Mitochondrial Myopathies, Leigh Syndrome, Pearson Syndrome, CPEO
12/40
12/40
TIRCON, NCT05522374: International NBIA Registry

Recruiting
N/A
2000
Europe, Canada, RoW
LMU Klinikum, Seventh Framework Programme, NBIA Alliance
Neurodegeneration With Brain Iron Accumulation (NBIA), Pantothenate Kinase-associated Neurodegeneration (PKAN), Beta-Propeller Protein-Associated Neurodegeneration (BPAN), Mitochondrial Membrane Protein Associated Neurodegeneration (MPAN), Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN), Kufor Rakeb Syndrome, Neuroferritinopathy, Aceruloplasminemia, Woodhouse Sakati Syndrome, COASY Protein-associated Neurodegeneration (CoPAN), PLA2G6-Associated Neurodegeneration (PLAN)
12/40
12/40
Boesch, Sylvia
NICOFA, NCT03761511 / 2017-002163-17: Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia

Withdrawn
2
225
Europe
Nicotinamide, Placebo
RWTH Aachen University, Assistance Publique - Hôpitaux de Paris
Friedreich Ataxia
06/25
12/25
PROFA, NCT05943002: Patient-reported, Health Economic and Psychosocial Outcomes in Friedreich Ataxia

Recruiting
N/A
200
Europe
German Center for Neurodegenerative Diseases (DZNE), McMaster University, Sorbonne University
Friedreich Ataxia
08/24
10/24
EFACTS, NCT02069509: Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies

Recruiting
N/A
1200
Europe, RoW
European Friedreich's Ataxia Consortium for Translational Studies
Friedreich's Ataxia
12/24
12/24
NCT06623890: A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it for the First Time

Recruiting
N/A
300
Europe, US, RoW
Omaveloxolone, SKYCLARYS, BIIB141
Reata, a wholly owned subsidiary of Biogen
Friedreich Ataxia
10/29
10/29
UNIFAI, NCT06016946: Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Recruiting
N/A
3000
Europe, Canada, US, RoW
Friedreich's Ataxia Research Alliance
Friedreich Ataxia
01/48
01/48
Karin, Ivan
EFACTS, NCT02069509: Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies

Recruiting
N/A
1200
Europe, RoW
European Friedreich's Ataxia Consortium for Translational Studies
Friedreich's Ataxia
12/24
12/24
UNIFAI, NCT06016946: Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Recruiting
N/A
3000
Europe, Canada, US, RoW
Friedreich's Ataxia Research Alliance
Friedreich Ataxia
01/48
01/48
Al-Tamami, Jasmina
NuPower, NCT05162768 / 2021-003907-16: Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)

Active, not recruiting
3
102
Europe, US, RoW
Elamipretide, MTP-131, Placebo
Stealth BioTherapeutics Inc.
Mitochondrial Myopathies, Mitochondrial Pathology, Mitochondrial DNA Mutation, Mitochondrial Diseases, Mitochondrial DNA Deletion, Mitochondrial DNA Depletion, Mitochondrial Metabolism Defect, Mitochondrial Complex I Deficiency
09/24
10/24
EFACTS, NCT02069509: Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies

Recruiting
N/A
1200
Europe, RoW
European Friedreich's Ataxia Consortium for Translational Studies
Friedreich's Ataxia
12/24
12/24
HSP-PBP, NCT03981276: Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders

Recruiting
N/A
2000
Europe
Clinical rating scale to measure disease severity and progression, Spastic Paraplegia Rating Scale (SPRS), Next-Gen Sequencing (NGS)
Dr. Rebecca Schule, German Federal Ministry of Education and Research, German Center for Neurodegenerative Diseases (DZNE)
Hereditary Spastic Paraplegia
08/39
08/41
UNIFAI, NCT06016946: Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study

Recruiting
N/A
3000
Europe, Canada, US, RoW
Friedreich's Ataxia Research Alliance
Friedreich Ataxia
01/48
01/48

Download Options